Cargando…

Bone loss caused by dopaminergic degeneration and levodopa treatment in Parkinson’s disease model mice

Accumulating evidence have shown the association of Parkinson’s disease (PD) with osteoporosis. Bone loss in PD patients, considered to be multifactorial and a result of motor disfunction, is a hallmark symptom that causes immobility and decreased muscle strength, as well as malnutrition and medicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handa, Kazuaki, Kiyohara, Shuichi, Yamakawa, Tomoyuki, Ishikawa, Koji, Hosonuma, Masahiro, Sakai, Nobuhiro, Karakawa, Akiko, Chatani, Masahiro, Tsuji, Mayumi, Inagaki, Katsunori, Kiuchi, Yuji, Takami, Masamichi, Negishi-Koga, Takako
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760231/ https://www.ncbi.nlm.nih.gov/pubmed/31551490 http://dx.doi.org/10.1038/s41598-019-50336-4

Ejemplares similares

A Delphinidin-Enriched Maqui Berry Extract Improves Bone Metabolism and Protects against Bone Loss in Osteopenic Mouse Models
por: Nagaoka, Masahiro, et al.
Publicado: (2019)

Effects of lipid metabolism on mouse incisor dentinogenesis
por: Kurotaki, Yutaro, et al.
Publicado: (2020)

Biological Effects of Anti-RANKL Antibody and Zoledronic Acid on Growth and Tooth Eruption in Growing Mice
por: Isawa, Motoki, et al.
Publicado: (2019)

Linagliptin Has Wide-Ranging Anti-Inflammatory Points of Action in Human Umbilical Vein Endothelial Cells
por: Nakamura, Yuya, et al.
Publicado: (2016)

A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia
por: Ueno, Shin-ichi, et al.
Publicado: (2020)

Association between pH regulation of the tumor microenvironment and immunological state
por: Hosonuma, Masahiro, et al.
Publicado: (2023)

Roles of monocarboxylate transporter subtypes in promotion and suppression of osteoclast differentiation and survival on bone
por: Imai, Hiroko, et al.
Publicado: (2019)

Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans
por: Herz, Damian M., et al.
Publicado: (2015)

Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism
por: Monnot, Cyril, et al.
Publicado: (2017)

Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's Disease
por: Antonini, Angelo, et al.
Publicado: (2023)

Exploring the levodopa-paradox of freezing of gait in dopaminergic medication-naïve Parkinson’s disease populations
por: Jansen, Jamie A. F., et al.
Publicado: (2023)

The Impact of Human Parvovirus B19 Infection on Heart Failure and Anemia with Reference to Iron Metabolism Markers in an Adult Woman
por: Nakamura, Yuya, et al.
Publicado: (2017)

Linagliptin Inhibits Interleukin-6 Production Through Toll-Like Receptor 4 Complex and Lipopolysaccharide-Binding Protein Independent Pathway in vitro Model
por: Saito, Hiroshi, et al.
Publicado: (2021)

Elder Abuse and Depressive Symptoms: Which is Cause and Effect? Bidirectional Longitudinal Studies From the JAGES
por: Koga, Chie, et al.
Publicado: (2020)

The association between elder abuse and refrainment from daily activities during the COVID-19 pandemic among older adults in Japan: A cross-sectional study from the Japan Gerontological Evaluation Study
por: Koga, Chie, et al.
Publicado: (2022)

Soy isoflavones inducing overt hypothyroidism in a patient with chronic lymphocytic thyroiditis: a case report
por: Nakamura, Yuya, et al.
Publicado: (2017)

Ascorbic acid can alleviate the degradation of levodopa and carbidopa induced by magnesium oxide
por: Miyaue, Noriyuki, et al.
Publicado: (2022)

Pharmacokinetics of Levodopa before and after Gastrointestinal Resection in Parkinson's Disease
por: Nagayama, Hiroshi, et al.
Publicado: (2015)

Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease
por: Nomoto, Masahiro, et al.
Publicado: (2018)

Concomitant use of magnesium oxide significantly decreases absorption of levodopa preparations in patients with Parkinson’s disease
por: Miyaue, Noriyuki, et al.
Publicado: (2023)

Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety
por: Othman, Ahmed A., et al.
Publicado: (2015)

Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report
por: Imbriani, Paola, et al.
Publicado: (2017)

Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome
por: Kimura, Masamichi, et al.
Publicado: (2015)

Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease
por: Conti, Valeria, et al.
Publicado: (2022)

Chronic Levodopa Administration Followed by a Washout Period Increased Number and Induced Phenotypic Changes in Striatal Dopaminergic Cells in MPTP-Monkeys
por: DiCaudo, Carla, et al.
Publicado: (2012)

Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently
por: Sato, Naoki, et al.
Publicado: (2019)

Levodopa-Induced Pseudopheochromocytoma
por: Cardoso, Joana, et al.
Publicado: (2023)

The potential hazard of drug-eluting stent-induced coronary vasospasm causing subacute stent thrombosis: a case report
por: Shibutani, Hiroki, et al.
Publicado: (2016)

Effect of Opicapone Tablets on Levodopa and 3‐O‐Methyldopa Pharmacokinetics in Healthy Japanese Subjects: Phase 1 Study
por: Nomoto, Masahiro, et al.
Publicado: (2020)

Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytes
por: Yamadera, Shiho, et al.
Publicado: (2018)

Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease
por: Hattori, Nobutaka, et al.
Publicado: (2019)

Levodopa-induced respiratory dysfunction confirmed by levodopa challenge test: A case report
por: Ko, Pan-Woo, et al.
Publicado: (2018)

Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
por: Othman, Ahmed A., et al.
Publicado: (2017)

Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet(®)), sustained‐release carbidopa‐levodopa (Sinemet(®) CR), and carbidopa‐levodopa‐entacapone (Stalevo(®))
por: Hsu, Ann, et al.
Publicado: (2015)

Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose
por: Nishikawa, Noriko, et al.
Publicado: (2022)

What Types of Greenspaces Are Associated with Depression in Urban and Rural Older Adults? A Multilevel Cross-Sectional Study from JAGES
por: Nishigaki, Miho, et al.
Publicado: (2020)

Association between Proximity of the Elementary School and Depression in Japanese Older Adults: A Cross-Sectional Study from the JAGES 2016 Survey
por: Nishida, Megumi, et al.
Publicado: (2021)

Mathematical Insights into the Effects of Levodopa
por: Reed, Michael C., et al.
Publicado: (2012)

Thrombocytopenia Associated with Levodopa Treatment
por: Lee, Ku-Eun, et al.
Publicado: (2013)

Orthostatic stability with intravenous levodopa
por: Siddiqi, Shan H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iufgak5s0aa2jbf8je5gp472gr